News coverage about Plains GP (NYSE:PAGP) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Plains GP earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned news coverage about the pipeline company an impact score of 47.5448383732481 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Plains GP (PAGP) traded down $0.15 during trading on Wednesday, reaching $23.26. The company had a trading volume of 1,840,000 shares, compared to its average volume of 1,420,000. The company has a market capitalization of $6,720.00, a PE ratio of 52.86 and a beta of 1.51. Plains GP has a fifty-two week low of $18.98 and a fifty-two week high of $34.63. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.78 and a current ratio of 1.00.

Plains GP (NYSE:PAGP) last posted its quarterly earnings results on Monday, November 6th. The pipeline company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.20). The firm had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.71 billion. Plains GP had a net margin of 0.25% and a return on equity of 0.50%. Plains GP’s revenue was up 13.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.39 EPS. research analysts predict that Plains GP will post 0.87 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 14th. Investors of record on Wednesday, January 31st will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.16%. The ex-dividend date is Tuesday, January 30th. Plains GP’s dividend payout ratio is 272.73%.

A number of brokerages have weighed in on PAGP. Barclays cut Plains GP from an “overweight” rating to an “equal weight” rating and set a $26.00 price target on the stock. in a research report on Wednesday. Credit Suisse Group began coverage on Plains GP in a research report on Thursday, January 4th. They issued an “outperform” rating and a $25.00 price target on the stock. Bank of America initiated coverage on Plains GP in a research report on Tuesday, January 9th. They issued a “neutral” rating on the stock. ValuEngine cut Plains GP from a “hold” rating to a “sell” rating in a report on Sunday, December 31st. Finally, BidaskClub cut Plains GP from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Plains GP has an average rating of “Hold” and an average target price of $25.71.

WARNING: This report was first posted by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at

About Plains GP

Plains GP Holdings, L.P. owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids (NGL), natural gas and refined products. The Company operates through three segments: Transportation, Facilities, and Supply and Logistics. Through its three business segments, the Company is engaged in the transportation, storage, terminaling and marketing of crude oil, NGL and natural gas.

Insider Buying and Selling by Quarter for Plains GP (NYSE:PAGP)

Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with's FREE daily email newsletter.